TotalMarketCap

Foghorn Therapeutics

FHTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$113.129 M

$1.91 -9.29%

Close of 6 Nov 2026

As of 6 Nov 2026, Foghorn Therapeutics (FHTX) has a market capitalization of $113.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$30.9M

#2858 by revenue

Earnings

-$74.3M

Loss-making

Shares outstanding

59,385,315

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #280BGM GroupBGM$118.9M
  2. #281NkartaNKTX$114.2M
  3. #282Foghorn TherapeuticsFHTX$113.1M
  4. #283Minerva NeurosciencesNERV$109.8M
  5. #284Kazia TherapeuticsKZIA$109.7M

What if Foghorn Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$475,485.80

Per share 249,599× higher

Bitcoin $1.53T

$25,727.71

Per share 13,505× higher

Apple $5.02T

$84,461.67

Per share 44,337× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Foghorn Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.